AAAAAA

   
Results: 1-22 |
Results: 22
Letter to the editor
Authors: Montgomery, SA Loft, H Sanchez, C Reines, EH Papp, M
Citation: Sa. Montgomery et al., Letter to the editor, PHARM TOX, 89(4), 2001, pp. 154-155
Escitalopram (S-Enantiomer of citalopram): Clinical efficacy and onset of action predicted from a rat model
Authors: Montgomery, SA Loft, H Sanchez, C Reines, EH Papp, M
Citation: Sa. Montgomery et al., Escitalopram (S-Enantiomer of citalopram): Clinical efficacy and onset of action predicted from a rat model, PHARM TOX, 88(5), 2001, pp. 282-286
Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder
Authors: Stein, DJ Montgomery, SA Kasper, S Tanghoj, P
Citation: Dj. Stein et al., Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder, INT CLIN PS, 16(6), 2001, pp. 357-361
A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression
Authors: Montgomery, SA
Citation: Sa. Montgomery, A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression, INT CLIN PS, 16(3), 2001, pp. 169-178
Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder
Authors: Montgomery, SA Kasper, S Stein, DJ Hedegaard, KB Lemming, OM
Citation: Sa. Montgomery et al., Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder, INT CLIN PS, 16(2), 2001, pp. 75-86
Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey
Authors: Wittchen, HU Carter, RM Pfister, H Montgomery, SA Kessler, RC
Citation: Hu. Wittchen et al., Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey, INT CLIN PS, 15(6), 2000, pp. 319-328
An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram
Authors: Markowitz, JS DeVane, CL Liston, HL Montgomery, SA
Citation: Js. Markowitz et al., An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram, INT CLIN PS, 15(6), 2000, pp. 329-333
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment
Authors: Brunello, N den Boer, JA Judd, LL Kasper, S Kelsey, JE Lader, M Lecrubier, Y Lepine, JP Lydiard, RB Mendlewicz, J Montgomery, SA Racagni, G Stein, MB Wittchen, HU
Citation: N. Brunello et al., Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment, J AFFECT D, 60(1), 2000, pp. 61-74
Pharmacotherapy of depression and mixed states in bipolar disorder
Authors: Montgomery, SA Schatzberg, AF Guelfi, JD Kasper, S Nemeroff, C Swann, A Zajecka, J
Citation: Sa. Montgomery et al., Pharmacotherapy of depression and mixed states in bipolar disorder, J AFFECT D, 59, 2000, pp. S39-S56
First international exchange on bipolar disorder
Authors: Montgomery, SA Keck, PE
Citation: Sa. Montgomery et Pe. Keck, First international exchange on bipolar disorder, J AFFECT D, 59, 2000, pp. S81-S88
Introduction - Understanding depression and its treatment: Restoration of chemical balance or creation of conditions promoting recovery?
Authors: Montgomery, SA
Citation: Sa. Montgomery, Introduction - Understanding depression and its treatment: Restoration of chemical balance or creation of conditions promoting recovery?, J CLIN PSY, 61, 2000, pp. 3-3
Social functioning in depression: A review
Authors: Hirschfeld, RMA Montgomery, SA Keller, MB Kasper, S Schatzberg, AF Moller, HJ Healy, D Baldwin, D Humble, M Versiani, M Montenegro, R Bourgeois, M
Citation: Rma. Hirschfeld et al., Social functioning in depression: A review, J CLIN PSY, 61(4), 2000, pp. 268-275
Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors
Authors: Montgomery, SA Judge, R
Citation: Sa. Montgomery et R. Judge, Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors, ACT PSYC SC, 101, 2000, pp. 9-16
Social phobia: diagnosis, severity and implications for treatment
Authors: Montgomery, SA
Citation: Sa. Montgomery, Social phobia: diagnosis, severity and implications for treatment, EUR ARCH PS, 249, 1999, pp. S1-S6
Treatment response in anxiety disorders - Introduction
Authors: Montgomery, SA
Citation: Sa. Montgomery, Treatment response in anxiety disorders - Introduction, EUR ARCH PS, 249, 1999, pp. NIL_2-NIL_2
Is severe depression a separate indication?
Authors: Montgomery, SA Lecrubier, Y
Citation: Sa. Montgomery et Y. Lecrubier, Is severe depression a separate indication?, EUR NEUROPS, 9(3), 1999, pp. 259-264
Alternatives to placebo-controlled trials in psychiatry
Authors: Montgomery, SA
Citation: Sa. Montgomery, Alternatives to placebo-controlled trials in psychiatry, EUR NEUROPS, 9(3), 1999, pp. 265-269
The failure of placebo-controlled studies
Authors: Montgomery, SA
Citation: Sa. Montgomery, The failure of placebo-controlled studies, EUR NEUROPS, 9(3), 1999, pp. 271-276
Predicting response: noradrenaline reuptake inhibition
Authors: Montgomery, SA
Citation: Sa. Montgomery, Predicting response: noradrenaline reuptake inhibition, INT CLIN PS, 14, 1999, pp. S21-S26
New developments in the treatment of depression
Authors: Montgomery, SA
Citation: Sa. Montgomery, New developments in the treatment of depression, J CLIN PSY, 60, 1999, pp. 10-15
Implications of the severity of social phobia
Authors: Montgomery, SA
Citation: Sa. Montgomery, Implications of the severity of social phobia, J AFFECT D, 50, 1998, pp. S17-S22
SSRIs in obsessive-compulsive disorder
Authors: Montgomery, SA
Citation: Sa. Montgomery, SSRIs in obsessive-compulsive disorder, PERSP PSYCH, 7, 1998, pp. 149-172
Risultati: 1-22 |